Neos Theraps Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NEOS THERAPS INC, and what generic alternatives to NEOS THERAPS INC drugs are available?
NEOS THERAPS INC has two approved drugs.
There are seven US patents protecting NEOS THERAPS INC drugs.
There are seven patent family members on NEOS THERAPS INC drugs in five countries.
Summary for Neos Theraps Inc
| International Patents: | 7 |
| US Patents: | 7 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Neos Theraps Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neos Theraps Inc | ADZENYS ER | amphetamine | SUSPENSION, EXTENDED RELEASE;ORAL | 204325-001 | Sep 15, 2017 | DISCN | Yes | No | 9,265,737 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-002 | Jun 19, 2017 | RX | Yes | No | 9,089,496 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-001 | Jun 19, 2017 | RX | Yes | No | 8,840,924 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-003 | Jun 19, 2017 | RX | Yes | Yes | 11,166,947 | See Plans and Pricing | See Plans and Pricing | ||||
| Neos Theraps Inc | ADZENYS ER | amphetamine | SUSPENSION, EXTENDED RELEASE;ORAL | 204325-001 | Sep 15, 2017 | DISCN | Yes | No | 9,017,731 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-002 | Jun 19, 2017 | RX | Yes | No | 8,840,924 | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Neos Theraps Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2726066 | See Plans and Pricing |
| European Patent Office | 3585439 | See Plans and Pricing |
| South Korea | 20190107655 | See Plans and Pricing |
| Australia | 2017353921 | See Plans and Pricing |
| Japan | 2020504763 | See Plans and Pricing |
| World Intellectual Property Organization (WIPO) | 2018085256 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
